QALYs and fairness: Health economic approaches to the fairness issue and their problems;QALYs und Gerechtigkeit: Ansätze und Probleme einer gesundheitsökonomischen Lösung der Fairnessproblematik

Gesundheitswesen

Volumn 73, Issue 10, 2011, Pages 688-695

  Klonschinski, A ^a   Lubbe W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

cost effectiveness; cost value analysis; equity weights; fairness; QALY

Indexed keywords

BIOETHICS; CHRONIC DISEASE; COST BENEFIT ANALYSIS; DISABLED PERSON; ECONOMICS; ETHICS; GERMANY; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; REVIEW;

BIOETHICS; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DISABLED PERSONS; GERMANY; HEALTH CARE RATIONING; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HUMANS; NATIONAL HEALTH PROGRAMS; QUALITY-ADJUSTED LIFE YEARS;

EID: 80054873397     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0030-1270468     Document Type: Article

References (52)

1. Drummond MF, Sculpher MJ, Torrance GW et al,., Hrsg Methods for the Economic Evaluation of Health Care Programmes. 3. Auflage Oxford Oxford University Press 2005
2. Weinstein MC, Torrance G, McGuire A. QALYs: The Basics. Value in Health 2009 12 Supplement I S5-S9
3. Nord E, Richardson J, Richardson J et al,. Maximizing health benefits vs. egalitarianism: An Australian survey of health issues. Social Science and Medicine 1995 41 1429-1437
4. Harris J. QALYfying the value of life. Journal of Medical Ethics 1987 13 117-123
5. Harris J. More and Better Justice. In: Bell JM, Mendus S, Hrsg.Philosophy and Medical Welfare Cambridge, New York u.a. CUP 1988 75-96
6. Broome J. Good, fairness and QALYs. In: Bell JM, Mendus, Hrsg.Philosophy and Medical Welfare Cambridge, New York u.a. CUP 1988 57-73
7. Lockwood M. Quality of Life and Resource Allocation. In: Bell JM, Mendus S, Hrsg.Philosophy and Medical Welfare Cambridge, New York u.a. CUP 1988 33-55
8. Nord E. Cost-Value-Analysis in Health Care: Making Sense out of QALYs. Cambridge CUP 1999
9. Hadorn D C. Setting health care priorities in Oregon. Cost-effectiveness meets the Rule of Rescue. JAMA 1991 265 17 2218-2225
10. Ubel P, Loewenstein G, Scanlon D et al,. Individual utilities are inconsistent with rationing choices: A partial explanation of why Oregon's cost-effectiveness list failed. Medical Decision Making 1996 16 108-116 (Pubitemid 126501138)
11. Ubel P, Richardson J, Pinto Prades J. Life-saving treatments and disabilities. Are all QALYs created equal? International Journal of Technology Assessment in Health Care 1999 15 4 738-748 (Pubitemid 30033520)
12. Schwappach D. Resource allocation, social values and the QALY: A review of the debate and empirical evidence. Health Expectations 2002 5 210-222 (Pubitemid 34988187)
13. Dolan P, Shaw R, Tsuchiya A et al,. QALY maximisation and people's preferences: a methodological review of the literature. Health Economics 2005 14 197-208 (Pubitemid 40253634)
14. Menzel P. How should what economists call social values be measured? The Journal of Ethics 1999 3 249-273
15. Williams A. Ethics and efficiency in the provision of health care. In: Bell JM, Mendus S, Hrsg.Philosophy and Medical Welfare Cambridge, New York u.a. CUP 1988 111-126
16. Culyer AJ. Commodities, characteristics of commodities, characteristics of people, utilities and the quality of life. In: Baldwin S, Godfrey C, Propper C, Hrsg.The quality of life: Perspectives and policies London Routledge 1990 9-27
17. Williams A. Economics, QALYs and medical ethics A health economist's perspective. Health Care Analysis 1995 3 221-234
18. Richardson J. The poverty of ethical analyses in economics and the unwarranted disregard of evidence. In: Murray, C. u.a., Hrsg.Summary Measures of Population Health: Concepts, Ethics, Measurement and Application Geneva WHO 2002 627-640
19. Richardson J, McKie J. Empiricism, ethics and orthodox economic theory: What is the appropriate basis for decision-making in the health sector? Social Science and Medicine 2005 60 265-275 (Pubitemid 39452543)
20. Hausman DM. The limits to Empirical Ethics. In: Murray, C. u.a., Hrsg.Summary Measures of Population Health: Concepts, Ethics, Measurement and Application Geneva WHO 2002 641-652
21. Hausman DM. Why not just ask? Preferences, Empirical Ethics and the role of ethical reflection. In: Wikler, Dan, Hrsg. From Fairness to Goodness, in Vorbereitung Online: http://philosophy.wisc.edu/hausman/papers/Hausman-why-not. pdf
22. Culyer AJ. The normative economics of health care finance and provision. Oxford Review of Economic Policy 1989 5 1 34-58
23. Nord E, Pinto JL, Richardson J et al,. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics 1999 8 25-39 (Pubitemid 29057353)
24. Menzel P, Gold M R, Nord E et al,. Toward a broader view of values in Cost-Effectiveness Analysis of health. Hastings Centre Report 1999 29 3 7-15
25. Nord E. The QALY: A measure of social value rather than individual utility. Health Economics 1994 3 2 89-93
26. Dolan P. The measurement of individual utility and social welfare. Journal of Health Economics 1998 17 39-52 (Pubitemid 28042037)
27. Ubel P, Richardson J, Menzel P. Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Economics 2000 9 127-136 (Pubitemid 30148159)
28. Nord E, Menzel P, Richardson J. The value of life: individual preferences and social choice: A comment to Magnus Johannesson. Health Economics 2003 12 873-877 (Pubitemid 37220637)
29. Hansson SO. Review: Cost-value-analysis in health care. Making sense out of QALYs by Erik Nord. The Philosophical Quarterly 2001 51 202 132-133
30. Osterdal LP. A note on cost-value analysis. Health Economics 2003 12 247-250
31. Williams A. Book Review: Making sense out of QALYs. Health Economics 2000 9 739-742
32. Ubel P, Nord E, Gold M et al,. Improving value measurement. Medical Care 2000 28 9 892-901
33. Brock D. Cost-effectiveness and disability discrimination. Economics and Philosophy 2009 25 27-47
34. Williams A. Intergenerational equity: An exploration of the fair innings argument. Health Economics 1997 6 117-132 (Pubitemid 27199138)
35. Williams A. The fair innings argument deserves a fairer hearing! Comments by Alan Williams on Nord and Johannesson. Health Economics 2001 10 583-585 (Pubitemid 32998370)
36. Oliver A. Prioritizing Health Care: Is health always an appropriate maximand? Medical Decision Making 2004 24 272-280 (Pubitemid 38656311)
37. Johannesson M. Should we aggregate relative or absolute changes in QALYs? Health Economics 2001 10 573-577 (Pubitemid 32998368)
38. Nord E. The desirability of a condition versus the well being and worth of a person. Health Economics 2001 10 579-581 (Pubitemid 32998369)
39. Brouwer WB, Culyer AJ, van Exel NJA et al,. Welfarism vs. extra-welfarism. Journal of Health Economics 2008 27 325-338
40. Dolan P, Kahneman D. Interpretations of health and their implications for the valuation of health. The Economic Journal 2008 118 215-234
41. Nord E. How can Societal Concerns for Fairness be Integrated into Economic Evaluations? Toward Cost-Value Analysis in Health Care. Das Gesundheitswesen 2009 71 Suppl. 1 S15-S19
42. Sinnott-Armstrong W. Consequentialism. Stanford Encyclopedia of Philosophy. 2006 online: http://plato.stanford.edu/entries/consequentialism Zugriff am 18.12.2009, 8:54 Uhr.
43. Sen A. Utilitarianism and welfarism. The Journal of Philosophy 1976 76 9 463-489
44. Hausman DM, McPherson MS. Economic Analysis, Moral Philosophy and Public Policy. Zweite Auflage. Cambridge CUP 2006
45. Schwappach DLB. Effizienz und Fairness: Bevölkerungspräferenzen für die Allokation von Ressourcen. Das Gesundheitswesen 2009 71 Suppl. 1 S9-S14
46. Hurley J. Welfarism, extra-welfarism and evaluative economic analysis in the health care sector. In: Barer M.; Getzen TE; Stoddart GL, Hrsg.Health, Health Care and Health Economics Chichester Wiley and Sons 1998 373-395
47. Anand P, Wailoo A. Utilities versus rights to publicly provided goods: Arguments and evidence from health care rationing. Economica 2000 67 543-577 (Pubitemid 32062835)
48. Lübbe W. Postutilitarismus in der Priorisierungsdebatte. ZEFQ 2009 103 99-103
49. Lübbe W. Measures of benefit, social values and claims: (How) Can the current health economic evaluation paradigms be amended to meet fairness objectives? Präsentation auf dem Workshop des Swiss HTA Project Value and Valuation of Health Technologies, Kartause Ittingen, 6. Nov. 2010 http://www.swisshta.ch/index.php?id=51
50. Lübbe W. Sollte sich das IQWiG auf indikationsübergreifende Kosten-Nutzen-Bewertungen mittels des QALY-Konzepts einlassen? Deutsche Medizinische Wochenschrift 2010 135 582-585
51. Wasem J. Kosten-Nutzen-Bewertung von Arzneimitteln: Eine unvermeidbare Abwägung. Deutsches Ärzteblatt 2008 105 9 A438-A440
52. Graf v.d. Schulenburg J-M, Greiner W, Dierks C. Methoden zur Ermittlung von Kosten-Nutzen-Relationen für Arzneimittel in Deutschland. Gesundheitsökonomie und Qualitätsmanagement 2010 15 S1-S28